Back to HomeBeta

ICD-10 Coding for Prostate Cancer with Metastasis(C61, C79.51)

Complete ICD-10-CM coding and documentation guide for Prostate Cancer with Metastasis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic Prostate CancerProstate Adenocarcinoma with Metastasis

Related ICD-10 Code Ranges

Complete code families applicable to Prostate Cancer with Metastasis

C61-C79Primary Range

Malignant neoplasms of male genital organs and secondary malignant neoplasms

This range includes codes for primary prostate cancer and its common metastatic sites such as bone and liver.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C61Malignant neoplasm of prostateUse when prostate cancer is confirmed as the primary site.
  • Biopsy-confirmed prostate cancer
  • Elevated PSA levels
C79.51Secondary malignant neoplasm of boneUse when bone metastasis from prostate cancer is confirmed.
  • Bone scan showing metastasis
  • PSA >50 ng/mL

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for prostate cancer with metastasis

Essential facts and insights about Prostate Cancer with Metastasis

The ICD-10 code for prostate cancer with bone metastasis is C61 for the primary site and C79.51 for the secondary site.

Primary ICD-10-CM Codes for prostate cancer with metastasis

Malignant neoplasm of prostate
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy-confirmed prostate cancer

Applicable To

  • Prostate adenocarcinoma

Excludes

  • Benign prostatic hyperplasia

Clinical Validation Requirements

  • Biopsy-confirmed prostate cancer
  • Elevated PSA levels

Code-Specific Risks

  • Misclassification if primary site is not confirmed

Coding Notes

  • Ensure documentation specifies prostate as the primary site.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use when the patient is receiving chemotherapy for prostate cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant (primary) neoplasm, unspecified

C80.1
Use C80.1 only if the primary site is not documented.

Secondary malignant neoplasm of bone marrow

C79.52
Use C79.52 if metastasis is specifically to bone marrow.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Prostate Cancer with Metastasis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C61.

Impact

Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential underpayment due to incorrect DRG

Mitigation Strategy

Thorough review of imaging reports, Regular coding audits

Impact

Reimbursement: Incorrect DRG assignment leading to potential underpayment., Compliance: Increased risk of audit due to unspecified primary site., Data Quality: Inaccurate cancer registry data.

Mitigation Strategy

Query provider to confirm primary site as prostate.

Impact

High risk of audit if primary site is not documented.

Mitigation Strategy

Ensure all clinical notes specify primary and secondary sites.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Prostate Cancer with Metastasis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Prostate Cancer with Metastasis

Use these documentation templates to ensure complete and accurate documentation for Prostate Cancer with Metastasis. These templates include all required elements for proper coding and billing.

Prostate cancer with bone metastasis

Specialty: Oncology

Required Elements

  • Primary site
  • Metastatic sites
  • Treatment details
  • Imaging and lab results

Example Documentation

Primary Site: Prostate adenocarcinoma. Metastatic Sites: L3 vertebra confirmed by PSMA PET. Treatment: Docetaxel infusion. Imaging: PSMA-PET shows progression in L3. Labs: PSA 412 ng/mL.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Prostate cancer with mets
Good Documentation Example
Prostate adenocarcinoma (C61) with PSMA-avid lesions in L3 vertebra (C79.51) and left lung (C78.00), Gleason 4+5, PSA 412 ng/mL
Explanation
The good example specifies primary and metastatic sites, enhancing coding accuracy.

Need help with ICD-10 coding for Prostate Cancer with Metastasis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more